Wednesday, August 19, 2026

FDA OKs Takeda's Orzeyful, which mimics brain chemical orexin to improve wakefulness, sleep
Narcolepsy treatment just took a big step beyond caffeine and patchwork meds. The FDA has cleared Orzeyful, the first drug aimed at the underlying biology of narcolepsy type 1, rather than just tampi…
This is a summary. Read the full article from the original source:
Read full article →